Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports

The Firm is investigating Tylenol lawsuits on behalf of individuals who may have suffered serious liver damage due to the acetaminophen in Tylenol over-the-counter medications.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm has heard from a number of individuals who allegedly suffered acetaminophen-induced liver damage following ingestion of a Tylenol-brand over-the-counter product. We are pleased to see that the federal Tylenol lawsuits are moving forward.

New York, New York (PRWEB) July 29, 2014

Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered serious liver injuries due to the acetaminophen in Tylenol-brand medications continue to move forward in a multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. According to an Order dated July 23rd, the Court has revised certain deadlines pertaining to bellwether case and discovery issues. Among other things, the Order stipulates that all core case-specific discovery is to be completed by November 3, 2014. By December 1, 2014, each party must suggest to the Court one Tylenol lawsuit from the Eligible Trial Pool as a possible candidate for the litigation’s first bellwether trial. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

“Our Firm has heard from a number of individuals who allegedly suffered acetaminophen-induced liver damage following ingestion of a Tylenol-brand over-the-counter product. We are pleased to see that the federal Tylenol lawsuits are moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who were allegedly harmed by a Tylenol-brand over-the-counter medication.

Tylenol Liver Damage Allegations
According to court documents, at least 147 Tylenol liver damage claims are currently pending in the litigation underway in the Eastern District of Pennsylvania. In many cases, plaintiffs claim that liver damage resulting from the acetaminophen in a Tylenol product occurred even though the medication was used in accordance with label directions. The complaints further allege that Johnson & Johnson and McNeil Consumer Healthcare failed to provide consumers with adequate warnings regarding the risks associated with Tylenol-brand medications.

The Philadelphia Inquirer recently reported that 78,000 people require emergency room care every year due to toxic reactions to acetaminophen. Such injuries also result in about 33,000 hospitalizations every year.* In April, the U.S. Food & Drug Administration (FDA) announced that prescription drugs containing more than 325 milligrams of acetaminophen were no longer considered safe and were being voluntarily removed from the market. ** However, according to a Bloomberg.com report, over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen. Last year, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medication.***

Victims of acetaminophen-related liver injuries that allegedly resulted from the use of a Tylenol product may be entitled to file their own claim in this litigation. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP's website. Free, confidential and no-obligation case reviews are available by calling 800-511-5092.

*articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
**latimes.com/science/sciencenow/la-sci-sn-extra-strength-acetaminophen-fda-20140428-story.html, LA Times, April 28, 2014
***bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitclaims.com/
https://plus.google.com/115936073311125306742?rel=author